125 related articles for article (PubMed ID: 24935137)
1. Multimodality imaging of cardiothoracic lymphoma.
Carter BW; Wu CC; Khorashadi L; Godoy MC; de Groot PM; Abbott GF; Lichtenberger JP
Eur J Radiol; 2014 Aug; 83(8):1470-82. PubMed ID: 24935137
[TBL] [Abstract][Full Text] [Related]
2. Imaging Evaluation of Malignant Chest Wall Neoplasms.
Carter BW; Benveniste MF; Betancourt SL; de Groot PM; Lichtenberger JP; Amini B; Abbott GF
Radiographics; 2016; 36(5):1285-306. PubMed ID: 27494286
[TBL] [Abstract][Full Text] [Related]
3. Extranodal lymphoma in the thorax: cross-sectional imaging findings.
Lee WK; Duddalwar VA; Rouse HC; Lau EW; Bekhit E; Hennessy OF
Clin Radiol; 2009 May; 64(5):542-9. PubMed ID: 19348852
[TBL] [Abstract][Full Text] [Related]
4. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
Chavdarova LI; Tzonevska AD; Piperkova EN
Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
[TBL] [Abstract][Full Text] [Related]
5. Cross-sectional evaluation of thoracic lymphoma.
Bae YA; Lee KS
Radiol Clin North Am; 2008 Mar; 46(2):253-64, viii. PubMed ID: 18619380
[TBL] [Abstract][Full Text] [Related]
6. Primitive neuroectodermal tumors of the chest wall (Askin tumors): CT and MR findings.
Winer-Muram HT; Kauffman WM; Gronemeyer SA; Jennings SG
AJR Am J Roentgenol; 1993 Aug; 161(2):265-8. PubMed ID: 8392786
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma.
Hagtvedt T; Seierstad T; Lund KV; Løndalen AM; Bogsrud TV; Smith HJ; Geier OM; Holte H; Aaløkken TM
Acta Radiol; 2015 Feb; 56(2):152-8. PubMed ID: 24585944
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of CT in the diagnosis and therapy of malignant thoracic cancer].
Kohno A; Narimatsu A
Gan To Kagaku Ryoho; 1982 Feb; 9(2):182-7. PubMed ID: 7184394
[TBL] [Abstract][Full Text] [Related]
9. MR imaging to detect chest wall and pleural involvement in patients with lymphoma: effect on radiation therapy planning.
Carlsen SE; Bergin CJ; Hoppe RT
AJR Am J Roentgenol; 1993 Jun; 160(6):1191-5. PubMed ID: 8498212
[TBL] [Abstract][Full Text] [Related]
10. Cross-sectional evaluation of thoracic lymphoma.
Bae YA; Lee KS
Thorac Surg Clin; 2010 Feb; 20(1):175-86. PubMed ID: 20378068
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients.
Mayerhoefer ME; Karanikas G; Kletter K; Prosch H; Kiesewetter B; Skrabs C; Porpaczy E; Weber M; Pinker-Domenig K; Berzaczy D; Hoffmann M; Sillaber C; Jaeger U; Müllauer L; Simonitsch-Klupp I; Dolak W; Gaiger A; Ubl P; Lukas J; Raderer M
Clin Cancer Res; 2014 Jun; 20(11):2984-93. PubMed ID: 24696320
[TBL] [Abstract][Full Text] [Related]
12. Can full-dose contrast-enhanced CT be omitted from an FDG-PET/CT staging examination in newly diagnosed FDG-avid lymphoma?
van Hamersvelt HP; Kwee TC; Fijnheer R; Beek FJ; de Klerk JM; Nievelstein RA
J Comput Assist Tomogr; 2014; 38(4):620-5. PubMed ID: 24681861
[TBL] [Abstract][Full Text] [Related]
13. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
Qiu L; Chen Y; Wu J
Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577
[TBL] [Abstract][Full Text] [Related]
14. Imaging of thoracic sarcomas of the chest wall, pleura, and lung.
Foran P; Colleran G; Madewell J; O'Sullivan PJ
Semin Ultrasound CT MR; 2011 Oct; 32(5):365-76. PubMed ID: 21963160
[TBL] [Abstract][Full Text] [Related]
15. Imaging the posterior mediastinum: a multimodality approach.
Occhipinti M; Heidinger BH; Franquet E; Eisenberg RL; Bankier AA
Diagn Interv Radiol; 2015; 21(4):293-306. PubMed ID: 25993732
[TBL] [Abstract][Full Text] [Related]
16. [Value of magnetic resonance tomography in Pancoast and other tumors with infiltration of the thoracic wall].
Bittner R; Kaiser D; Loddenkemper R; Schörner W; Felix R
Pneumologie; 1990 Feb; 44(2):62-9. PubMed ID: 2326242
[TBL] [Abstract][Full Text] [Related]
17. MR imaging in the management of thoracic malignancies.
Templeton PA; Zerhouni EA
Radiol Clin North Am; 1989 Nov; 27(6):1099-111. PubMed ID: 2685876
[TBL] [Abstract][Full Text] [Related]
18. Comparison of PET-CT and magnetic resonance diffusion weighted imaging with body suppression (DWIBS) for initial staging of malignant lymphomas.
Stéphane V; Samuel B; Vincent D; Joelle G; Remy P; Francois GG; Jean-Pierre T
Eur J Radiol; 2013 Nov; 82(11):2011-7. PubMed ID: 23932096
[TBL] [Abstract][Full Text] [Related]
19. [The role of 18F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) in liposarcoma of the chest wall].
Yamamoto H; Sugimoto S; Miyoshi K; Yamamoto H; Soh J; Yamane M; Toyooka S; Oto T; Miyoshi S
Kyobu Geka; 2014 Jan; 67(1):4-8. PubMed ID: 24743405
[TBL] [Abstract][Full Text] [Related]
20. Lymphoproliferative disorders presenting as mediastinal neoplasms.
Petersdorf SH; Wood DE
Semin Thorac Cardiovasc Surg; 2000 Oct; 12(4):290-300. PubMed ID: 11154724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
